BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16996232)

  • 1. Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes.
    Niv N; Hser YI
    Drug Alcohol Depend; 2007 Mar; 87(2-3):194-201. PubMed ID: 16996232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of persistent pain with out-patient addiction treatment outcomes and service utilization.
    Caldeiro RM; Malte CA; Calsyn DA; Baer JS; Nichol P; Kivlahan DR; Saxon AJ
    Addiction; 2008 Dec; 103(12):1996-2005. PubMed ID: 18855809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's programs versus mixed-gender day treatment: results from a randomized study.
    Kaskutas LA; Zhang L; French MT; Witbrodt J
    Addiction; 2005 Jan; 100(1):60-9. PubMed ID: 15598193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes among women and men methamphetamine abusers in California.
    Hser YI; Evans E; Huang YC
    J Subst Abuse Treat; 2005 Jan; 28(1):77-85. PubMed ID: 15723735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in outcomes in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Lynch FL; Dickinson DM; Bennett MD
    J Addict Dis; 2004; 23(2):47-70. PubMed ID: 15132342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of substance abuse severity measures from administrative data.
    McCamant LE; Zani BG; McFarland BH; Gabriel RM
    Drug Alcohol Depend; 2007 Jan; 86(1):37-45. PubMed ID: 16806738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes.
    Moggi F; Giovanoli A; Strik W; Moos BS; Moos RH
    Drug Alcohol Depend; 2007 Jan; 86(1):75-83. PubMed ID: 16782286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employment and work among drug court clients: 12-month outcomes.
    Leukefeld C; Webster JM; Staton-Tindall M; Duvall J
    Subst Use Misuse; 2007; 42(7):1109-26. PubMed ID: 17668328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Treatment Outcomes for Substance-Abusing Women: A Retrospective Study.
    Comfort M; Kaltenbach KA
    Subst Abus; 2000 Mar; 21(1):33-45. PubMed ID: 12466646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employed men and women substance abusers: job troubles and treatment outcomes.
    Slaymaker VJ; Owen PL
    J Subst Abuse Treat; 2006 Dec; 31(4):347-54. PubMed ID: 17084788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes.
    Pirard S; Sharon E; Kang SK; Angarita GA; Gastfriend DR
    Drug Alcohol Depend; 2005 Apr; 78(1):57-64. PubMed ID: 15769558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of substance-abusing women on welfare. Findings from the evaluation of CASAWORKS for Families pilot demonstration.
    Gutman MA; Ketterlinus RD; McLellan AT
    Eval Rev; 2003 Dec; 27(6):597-628. PubMed ID: 14650277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of substance abuse treatment retention among women and men in an HMO.
    Mertens JR; Weisner CM
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1525-33. PubMed ID: 11045861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Health Realization and 12-Step treatment in women's residential substance abuse treatment programs.
    Banerjee K; Howard M; Mansheim K; Beattie M
    Am J Drug Alcohol Abuse; 2007; 33(2):207-15. PubMed ID: 17497543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of short-term treatment outcomes among California's Proposition 36 participants.
    Hser YI; Evans E; Teruya C; Huang D; Anglin MD
    Eval Program Plann; 2007 May; 30(2):187-96. PubMed ID: 17689324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.